These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5506081)

  • 1. A clinical evaluation of pyridostigmin bromide in the reversal of curarization.
    Gotta AW; Sullivan CA
    Can Anaesth Soc J; 1970 Sep; 17(5):527-34. PubMed ID: 5506081
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of d-tubocurarine- and pancuronium-induced neuromuscular blockades by pyridostigmine in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1973 Nov; 39(5):504-9. PubMed ID: 4355635
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
    Long G; Marsh HM
    Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
    Katz RL
    Anesthesiology; 1967; 28(3):528-34. PubMed ID: 6023525
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of certain drugs upon amitriptyline induced electrocardiographic changes.
    Nymark M; Rasmussen J
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):148-56. PubMed ID: 6013087
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative times to peak effect and durations of action of neostigmine and pyridostigmine.
    Miller RD; Van Nyhuis LS; Eger EI; Vitez TS; Way WL
    Anesthesiology; 1974 Jul; 41(1):27-33. PubMed ID: 4834375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical studies on pyridostigmine as an antagonist of non-depolarizing blocking agents].
    Nakao H; Fukushima K
    Masui; 1976 Feb; 25(2):136-42. PubMed ID: 943598
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma concentration of pyridostigmine during the antagonism of neuromuscular block.
    Williams NE; Calvey TN; Chan K
    Br J Anaesth; 1983 Jan; 55(1):27-31. PubMed ID: 6821619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine].
    Stoyanov M; Müller H; Lobisch M; Hempelmann G
    Anaesthesist; 1984 Oct; 33(10):499-503. PubMed ID: 6239562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atropine, 2-PAM, or pyridostigmine in euvolemic or hemorrhagic conscious swine.
    Wade CE; Waring PP; Trail DS; Gildengorin VL; Williams BF; Bonner GD
    Mil Med; 1988 Sep; 153(9):470-6. PubMed ID: 3141840
    [No Abstract]   [Full Text] [Related]  

  • 12. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children.
    Yamashita M; Tajima K
    Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on muscarinic receptors of various agents in reversal of neuro-muscular blockade: a study evaluating atropine, glycopyrron, neostigmine and pyridostigmine.
    Eriksen S; Hansen EK; Hasselstrøm L
    Acta Anaesthesiol Scand; 1978; 22(4):447-57. PubMed ID: 726861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopyrrolate as a substitute for atropine in neostigmine reversal of muscle relaxant drugs.
    Ramamurthy S; Shaker MH; Winnie AP
    Can Anaesth Soc J; 1972 Jul; 19(4):399-411. PubMed ID: 5042867
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning.
    Worek F; Kleine A; Szinicz L
    Hum Exp Toxicol; 1995 Aug; 14(8):634-42. PubMed ID: 7576830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of curarization with atropine-neostigmine mixture in patients with congenital cardiac disease.
    Salem MR; Ylagan LB; Angel JJ; Vedam VS; Collins VJ
    Br J Anaesth; 1970 Nov; 42(11):991-8. PubMed ID: 5488363
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of administration of atropine and neostigmine in man.
    Ovassapian A
    Anesth Analg; 1969; 48(2):219-23. PubMed ID: 5813068
    [No Abstract]   [Full Text] [Related]  

  • 19. Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
    Miller RD; Roderick L
    Br J Pharmacol; 1977 Aug; 60(4):555-8. PubMed ID: 907868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of atropine and neostigmine on heart rate and rhythm. Recommendation for their use to reverse residual neuromuscular block.
    Rosner V; Kepes ER; Foldes FF
    Br J Anaesth; 1971 Nov; 43(11):1066-74. PubMed ID: 5131460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.